TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bio Vitos Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Turnover |
2,012
|
882
|
815 |
Financial expenses |
0
![]() |
0
|
1 |
Earnings before taxes |
-8,642
|
-9,957
|
-10,146 |
EBITDA |
-2,354
|
-5,196
|
-5,478 |
Total assets |
22,783
|
17,675
|
25,811 |
Current assets |
3,434
|
3,490
|
8,070 |
Current liabilities |
677
|
1,020
|
1,427 |
Equity capital |
22,105
|
16,654
|
24,384 |
- share capital |
2,873
|
2,067
|
1,262 |
Employees (average) |
1
|
5
|
6 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Solvency |
97.0%
|
94.2%
|
94.5% |
Turnover per employee |
2,012
|
176
|
136 |
Profit as a percentage of turnover |
-429.5%
|
-1128.9%
|
-1244.9% |
Return on assets (ROA) |
-37.9%
|
-56.3%
|
-39.3% |
Current ratio |
507.2%
|
342.2%
|
565.5% |
Return on equity (ROE) |
-39.1%
|
-59.8%
|
-41.6% |
Change turnover | |||
Change turnover % |
18%
|
265% | |
Chg. No. of employees | |||
Chg. No. of employees % |
-17%
|
20% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.